Mantle Cell Lymphoma — Trials

Mantle Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 180
Recruiting: 93
Ph III recruiting: 6
Growth YoY: —
Industry share: 26%
Top sponsor: City of Hope Medical Center
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07697339	HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma	not yet recruiting	Phase 1	40	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.INDUSTRY	0	Jul 13, 2026	clinicaltrials
NCT07578077	Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma	not yet recruiting	Phase 1 / Phase 2	58	City of Hope Medical CenterOTHER	1	May 11, 2026